# Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin

Study · id `cardio:ct-nct02426294` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02426294](<https://clinicaltrials.gov/study/NCT02426294>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02426294

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 154 participants.

## Technical summary

Registry record NCT02426294. Randomized; no masking; primary purpose treatment. Start 2015-02 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 154 participants (planned count; ClinicalTrials.gov record NCT02426294, source copy `cardio:ctgov-nct02426294-2015-04-24`, retrieved 2026-10-26)
- Start date: 2015-02 (registry gives no type) (ClinicalTrials.gov record NCT02426294, source copy `cardio:ctgov-nct02426294-2015-04-24`, retrieved 2026-10-26)
- Primary completion: 2015-12 (anticipated) (ClinicalTrials.gov record NCT02426294, source copy `cardio:ctgov-nct02426294-2015-04-24`, retrieved 2026-10-26)
- Completion: 2016-05 (anticipated) (ClinicalTrials.gov record NCT02426294, source copy `cardio:ctgov-nct02426294-2015-04-24`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT02426294, source copy `cardio:ctgov-nct02426294-2015-04-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02426294-2015-04-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin
- Condition: Type 2 Diabetes Mellitus
- Intervention (Drug): Pioglitazone
- Intervention (Drug): Glimepiride
- Lead sponsor: Pusan National University Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Pusan National University Hospital (`cardio:org-pusan-national-university-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study (`cardio:pubmed-31339011`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 43b84fe6d8d5979bb84c72c389be1d21d4f796d13dbfe33dae6c002fad8abc60
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
